These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9048115)

  • 21. [Therapy of lipid metabolism disorders].
    Schlierf G
    Internist (Berl); 1984 May; 25(5):275-81. PubMed ID: 6329983
    [No Abstract]   [Full Text] [Related]  

  • 22. Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reduction.
    Ballantyne CM
    Am Heart J; 2004 Jul; 148(1 Suppl):S3-8. PubMed ID: 15211326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study].
    Forster T
    Orv Hetil; 2001 Jul; 142(29):1588-9. PubMed ID: 11494751
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological treatment for hyperlipidaemia--the best preventive measure?
    Rosengren A; Swedberg K
    Eur Heart J; 1999 Feb; 20(4):245-6. PubMed ID: 10099914
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipoprotein analysis.
    Colyar MR
    Adv Nurse Pract; 2002 May; 10(5):30-2. PubMed ID: 12420528
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategies for optimizing lipid treatment outcomes.
    Spellman CW
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S12-5. PubMed ID: 12572625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secondary prevention of coronary artery disease with lipid-lowering drugs].
    Delahaye F; De Gevigney G
    Ann Med Interne (Paris); 2001 Apr; 152(3):184-7. PubMed ID: 11431578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
    Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573
    [No Abstract]   [Full Text] [Related]  

  • 30. [Also elderly patients with hyperlipidemia and coronary disease need lipid lowering agents].
    Hellénius ML
    Lakartidningen; 2001 Sep; 98(39):4188-90. PubMed ID: 11680152
    [No Abstract]   [Full Text] [Related]  

  • 31. [The diagnosis and treatment of coronary heart disease in chronic renal failure].
    Belialov FI
    Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of reasons for discontinuation of treatment for dyslipidemia in secondary prevention of coronary heart disease].
    Tyszecka G
    Przegl Lek; 1999; 56(11):709-15. PubMed ID: 10800583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dyslipidaemia and coronary heart disease: nature vs nurture.
    Hegele RA
    Br J Hosp Med; 1995 Aug 16-Sep 5; 54(4):143-6. PubMed ID: 7582364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy and clinical trials.
    Curr Opin Lipidol; 1995 Dec; 6(6):B77-82. PubMed ID: 8750254
    [No Abstract]   [Full Text] [Related]  

  • 35. Are the massive diet fat-heart and coronary drug studies justified? A critical commentary.
    Roberts HJ
    Angiology; 1968 Dec; 19(12):652-64. PubMed ID: 4882422
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of dyslipidemia in adults.
    Ahmed SM; Clasen ME; Donnelly JE
    Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness of antihyperlipidemic drug management in clinical practice.
    Andrade SE; Saperia GM; Berger ML; Platt R
    Clin Ther; 1999 Nov; 21(11):1973-87. PubMed ID: 10890267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of lipemia-lowering agents in the secondary prevention of myocardial infarct].
    Tullio D
    Clin Ter; 1986 Feb; 116(3):221-35. PubMed ID: 3516543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.